Literature DB >> 25771981

Step-wise and punctuated genome evolution drive phenotype changes of tumor cells.

Aleksei Stepanenko1, Svitlana Andreieva2, Kateryna Korets2, Dmytro Mykytenko2, Nataliya Huleyuk3, Yegor Vassetzky4, Vadym Kavsan2.   

Abstract

The pattern of genome evolution can be divided into two phases: the step-wise continuous phase (step-wise clonal evolution, stable dominant clonal chromosome aberrations (CCAs), and low frequency of non-CCAs, NCCAs) and punctuated phase (marked by elevated NCCAs and transitional CCAs). Depending on the phase, system stresses (the diverse CIN promoting factors) may lead to the very different phenotype responses. To address the contribution of chromosome instability (CIN) to phenotype changes of tumor cells, we characterized CCAs/NCCAs of HeLa and HEK293 cells, and their derivatives after genotoxic stresses (a stable plasmid transfection, ectopic expression of cancer-associated CHI3L1 gene or treatment with temozolomide) by conventional cytogenetics, copy number alterations (CNAs) by array comparative genome hybridization, and phenotype changes by cell viability and soft agar assays. Transfection of either the empty vector pcDNA3.1 or pcDNA3.1_CHI3L1 into 293 cells initiated the punctuated genome changes. In contrast, HeLa_CHI3L1 cells demonstrated the step-wise genome changes. Increased CIN correlated with lower viability of 293_pcDNA3.1 cells but higher colony formation efficiency (CFE). Artificial CHI3L1 production in 293_CHI3L1 cells increased viability and further contributed to CFE. The opposite growth characteristics of 293_CHI3L1 and HeLa_CHI3L1 cells were revealed. The effect and function of a (trans)gene can be opposite and versatile in cells with different genetic network, which is defined by genome context. Temozolomide treatment of 293_pcDNA3.1 cells intensified the stochastic punctuated genome changes and CNAs, and significantly reduced viability and CFE. In contrast, temozolomide treatment of HeLa_CHI3L1 cells promoted the step-wise genome changes, CNAs, and increased viability and CFE, which did not correlate with the ectopic CHI3L1 production. Thus, consistent coevolution of karyotypes and phenotypes was observed. CIN as a driving force of genome evolution significantly influences growth characteristics of tumor cells and should be always taken into consideration during the different experimental manipulations.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aneuploidy; Cancer gene; Chromosome instability; Tumor heterogeneity; YKL-40

Mesh:

Substances:

Year:  2014        PMID: 25771981     DOI: 10.1016/j.mrfmmm.2014.12.006

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  12 in total

1.  Recurring genomic structural variation leads to clonal instability and loss of productivity.

Authors:  Arpan A Bandyopadhyay; Sofie A O'Brien; Liang Zhao; Hsu-Yuan Fu; Nandita Vishwanathan; Wei-Shou Hu
Journal:  Biotechnol Bioeng       Date:  2018-10-27       Impact factor: 4.530

Review 2.  Systemic and rapid restructuring of the genome: a new perspective on punctuated equilibrium.

Authors:  Lydia R Heasley; Nadia M V Sampaio; Juan Lucas Argueso
Journal:  Curr Genet       Date:  2020-11-07       Impact factor: 3.886

3.  Temozolomide promotes genomic and phenotypic changes in glioblastoma cells.

Authors:  Aleksei A Stepanenko; Svitlana V Andreieva; Kateryna V Korets; Dmytro O Mykytenko; Vladimir P Baklaushev; Nataliya L Huleyuk; Oksana A Kovalova; Kateryna V Kotsarenko; Vladimir P Chekhonin; Yegor S Vassetzky; Stanislav S Avdieiev; Vladimir V Dmitrenko
Journal:  Cancer Cell Int       Date:  2016-05-05       Impact factor: 5.722

4.  Why it is crucial to analyze non clonal chromosome aberrations or NCCAs?

Authors:  Henry H Q Heng; Sarah M Regan; Guo Liu; Christine J Ye
Journal:  Mol Cytogenet       Date:  2016-02-13       Impact factor: 2.009

5.  Emergence of clonal chromosomal alterations during the mesenchymal stromal cell cultivation.

Authors:  Tamara Borgonovo; Maria Marlene Solarewicz; Isadora May Vaz; Debora Daga; Carmen Lúcia Kuniyoshi Rebelatto; Alexandra Cristina Senegaglia; Enilze Ribeiro; Iglenir João Cavalli; Paulo Slud Brofman
Journal:  Mol Cytogenet       Date:  2015-12-01       Impact factor: 2.009

6.  Speciation Theory of Carcinogenesis Explains Karyotypic Individuality and Long Latencies of Cancers.

Authors:  Ankit Hirpara; Mathew Bloomfield; Peter Duesberg
Journal:  Genes (Basel)       Date:  2018-08-09       Impact factor: 4.096

7.  Allele Loss and Reduced Expression of CYCLOPS Genes is a Characteristic Feature of Chromophobe Renal Cell Carcinoma.

Authors:  Riuko Ohashi; Peter Schraml; Aashil Batavia; Silvia Angori; Patrik Simmler; Niels Rupp; Yoichi Ajioka; Esther Oliva; Holger Moch
Journal:  Transl Oncol       Date:  2019-06-11       Impact factor: 4.243

8.  MEK inhibitor enhanced the antitumor effect of oxaliplatin and 5‑fluorouracil in MEK1 Q56P‑mutant colorectal cancer cells.

Authors:  Changwen Jing; Huizi Li; Yuanyuan Du; Haixia Cao; Siwen Liu; Zhuo Wang; Rong Ma; Jifeng Feng; Jianzhong Wu
Journal:  Mol Med Rep       Date:  2018-12-07       Impact factor: 2.952

9.  Identification of novel breakpoints for locus- and region-specific translocations in 293 cells by molecular cytogenetics before and after irradiation.

Authors:  Regina L Binz; Erming Tian; Ratan Sadhukhan; Daohong Zhou; Martin Hauer-Jensen; Rupak Pathak
Journal:  Sci Rep       Date:  2019-07-22       Impact factor: 4.379

10.  Is cancer progression caused by gradual or simultaneous acquisitions of new chromosomes?

Authors:  Mathew Bloomfield; Peter Duesberg
Journal:  Mol Cytogenet       Date:  2018-01-15       Impact factor: 2.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.